Using Endometrial Regenerative Cells for Critical Limb Ischemia
Author Information
Author(s): Michael P. Murphy, Hao Wang, Amit N. Patel, Suman Kambhampati, Niren Angle, Kyle Chan, Annette M. Marleau, Andrzej Pyszniak, Ewa Carrier, Thomas E. Ichim, Neil H. Riordan
Primary Institution: Indiana University School of Medicine
Hypothesis
Can allogeneic endometrial regenerative cells serve as an effective treatment for critical limb ischemia?
Conclusion
Endometrial regenerative cells may provide a promising 'off the shelf' treatment for critical limb ischemia, potentially improving outcomes for patients ineligible for other interventions.
Supporting Evidence
- Endometrial regenerative cells have shown potential in stimulating angiogenesis.
- Animal studies indicated that ERC treatment preserved limb function in ischemic conditions.
- ERCs can be expanded in culture without losing their differentiation ability.
Takeaway
Doctors are looking at using special cells from menstrual blood to help people with serious leg problems caused by poor blood flow, which could help them avoid amputations.
Methodology
The study involved injecting endometrial regenerative cells into mice with induced limb ischemia to assess their angiogenic potential.
Limitations
The study's results are based on preliminary animal experiments, and clinical applications are still in the early stages.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website